Tyndall MW - Search Results

1

Factors associated with public injecting among users of Vancouver's supervised injection facility.

McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, Montaner JS, Kerr T. McKnight I, et al. Among authors: tyndall mw. Am J Drug Alcohol Abuse. 2007;33(2):319-25. doi: 10.1080/00952990601175102. Am J Drug Alcohol Abuse. 2007. PMID: 17497555

2

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8. doi: 10.1097/00126334-200301010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12514408

3

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: tyndall mw. CMAJ. 2003 Sep 30;169(7):656-61. CMAJ. 2003. PMID: 14517122 Free PMC article.

4

Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.

Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Kerr T, et al. Among authors: tyndall mw. CMAJ. 2003 Oct 14;169(8):759-63. CMAJ. 2003. PMID: 14557313 Free PMC article.

5

Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention.

Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. Can J Public Health. 2003 Sep-Oct;94(5):355-9. doi: 10.1007/BF03403560. Can J Public Health. 2003. PMID: 14577743 Free PMC article.

6

Rationale for evaluating North America's first medically supervised safer-injecting facility.

Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW. Wood E, et al. Among authors: tyndall mw. Lancet Infect Dis. 2004 May;4(5):301-6. doi: 10.1016/S1473-3099(04)01006-0. Lancet Infect Dis. 2004. PMID: 15120347

7

Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.

Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: tyndall mw. Antivir Ther. 2004 Apr;9(2):229-35. Antivir Ther. 2004. PMID: 15134185 Clinical Trial.

8

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: tyndall mw. CMAJ. 2004 Sep 28;171(7):731-4. doi: 10.1503/cmaj.1040774. CMAJ. 2004. PMID: 15451834 Free PMC article.

9

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.

Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: tyndall mw. Harm Reduct J. 2004 Nov 9;1(1):9. doi: 10.1186/1477-7517-1-9. Harm Reduct J. 2004. PMID: 15535885 Free PMC article.

10

Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Collins CL, Kerr T, Kuyper LM, Li K, Tyndall MW, Marsh DC, Montaner JS, Wood E. Collins CL, et al. Among authors: tyndall mw. J Urban Health. 2005 Jun;82(2):276-84. doi: 10.1093/jurban/jti051. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters